港股異動 | BC科技集團(0863.HK)大漲超16% 股價創約3年新高
格隆匯2月16日丨區塊鏈概念股BC科技集團(0863.HK)今日高開高走,現大漲16.74%報20.5港元,股價創2018年2月22日以來約3年新高,暫成交7109萬港元,最新總市值78億港元。該股去年累漲124.75%,今年以來延續漲勢,2月份迄今已累漲超57%。特斯拉近期表示已購買價值15億美元比特幣,並將在不久的將來接受比特幣付款,比特幣因此開啟暴漲模式,今日一度升至50000美元/枚上方,再創歷史新高。此外據悉,BC科技集團曾於1月7日獲股東張衝在場外以每股均價15.5港元增持1200萬股,涉資約1.86億港元。增持後,其持股比例由3.33%上升至6.88%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.